ABBV authorizes new $5B buyback: http://finance.yahoo.com/news/abbvie-announces-5-billion-increase-130000579.html ABBV repurchased $3.8B of stock in 2016 to offset the issuance of shares in the Stemcentryx deal (#msg-122248289).